@ShahidNShah
Europe’s Largest Initiative to Accelerate Therapy Development for COVID-19 Launched
A European consortium has been launched to accelerate the discovery and development of urgently needed medicines to treat SARS-CoV-2, the virus that causes COVID-19.
Corona Accelerated R&D in Europe (CARE), is the largest undertaking of its kind dedicated to creating effective therapies with a positive safety profile and repurposing existing therapies for the pandemic.
It aims to boost R&D by bringing together the leading expertise and projects of 37 teams from academic, non-profit research institutions and pharmaceutical companies into a comprehensive drug discovery engine. It will integrate partners’ COVID-19 projects ongoing since February 2020.
The five-year project is supported by the Innovative Medicines Initiative (IMI) and has received a grant of €77.7 million, funded by cash contributions from the European Union and contributions from 11 European Federation of Pharmaceutical Industries and Associations (EFPIA) companies and three IMI-associated partners.
Researchers will undertake drug repositioning; small-molecule drug discovery based on in silico screening and profiling of candidate compounds; and virus neutralising antibody discovery.
After testing in the laboratory, the project will advance the most promising drug candidates to clinical trials in humans.
Read on mobihealthnews.com
Continue reading at mobihealthnews.com
Make faster decisions with community advice
Next Article
-
Following 300% growth in 2020, virtual diabetes care company Podimetrics lands another $8M
Somerville, Massachusetts-based virtual diabetes care company Podimetrics has added yet another $8 million to its Series B-2 funding, bringing the round’s closing total to $24.6 million, the …
Posted Aug 21, 2020 Virtual care Diabetic Foot Ulcers